Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles via Google Scholar Search for Related Content

Preliminary Program: SATURDAY MAY 20

CME Courses 1-3

9 a.m.-4 p.m.

CME Courses 4-9

10 a.m.-5 p.m.

APA Member Center Opens

Publishers' Bookfair Opens

Registration/Course Enrollment Opens

12:30 p.m.-3:30 p.m.

Industry-Supported Symposia

IS1. New Augmentation Strategies in Depression for Better Outcomes

Supported by GlaxoSmithKline

1. Polypharmacy in Depression: How Often is it Used and Why? Joshua A. Israel, M.D.
   
2. "How To" Augmentation Strategies in Resistant Depression Charles DeBattista, M.D.
   
3. When Does Polypharmacy Lead to Higher Remission Rates? Jonathan E. Alpert, M.D.
   
4. Adding Psychotherapy: Pearls for Improved Outcomes Amy Farabaugh, Ph.D.
   
5. Pharmacological Antidotes for Antidepressant-Induced Side Effects Anita H. Clayton, M.D.
   

IS2. Strategies for Maintaining Wellness in Patients With Bipolar Disorder: Moving Beyond Efficacy to Effectiveness Supported by Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc.

1. Impact of Misdiagnosis of Bipolar Disorder on Patient Outcomes Claudia F. Baldassano, M.D.
   
2. Brains and Genes: Implications for the Treatment of Bipolar Disorder Kiki D. Chang, M.D.
   
3. Evaluation of Clinical Trials in Bipolar Disease Gary S. Sachs, M.D.
   
4. Impact of Patient Satisfaction With Treatment on Treatment Outcomes Holly A. Swartz, M.D.
   

IS3. Navigating the Maze: Understanding Methods, Results, and Risks in Psychiatric Research Supported by Forest Laboratories, Inc.

1. Assessing Statistical and Clinical Significance in Medical Research David J. Kupfer, M.D.
   
2. All Risk Factors Are Not Created Equal: The Importance of Defining and Interpreting Risk on Medical Decision Making and Patient Care Helena C. Kraemer, Ph.D.
   
3. Determining Efficacy: Sound Clinical Trial Design and Interpretation Cornelius Katona, M.D.
   
4. Treating Depression in Children and Adolescents: What's a Clinician to Do? Jeff Q. Bostic, M.D.
   
5. How to Treat in the Absence of Scientific Evidence: A Focus on Anxiety Disorders in the Elderly Eric J. Lenze, M.D.
   

IS4. Bridging Sleep Science and Public Policy Supported by Takeda Pharmaceuticals North America, Inc.

1. The Science of Sleep David N. Neubauer, M.D.
   
2. Adolescents and School Start Times: The Intersection of Research and Public Policy R. Robert Auger, M.D.
   
3. Shiftwork, Sleep, and Performance Gregory Belenky, M.D.
   
4. Medical Education and Resident Duty Hours Phyllis C. Zee, M.D.
   
5. Insomnia and Public Policy Daniel J. Buysse, M.D.
   

1 p.m.-5 p.m.

CME Courses 10-14

6 p.m.-9 p.m.

Industry-Supported Symposia

IS5. Mania in Special Populations Supported by Shire US, Inc.

1. Recent Developments in the Treatment of Mania Robert M.A. Hirschfeld, M.D.
   
2. Recognition and Management of Child and Adolescent Bipolar Disorder Karen D. Wagner, M.D.
   
3. Bipolar Disorders in Women: Clinical and Metabolic Correlates Natalie L. Rasgon, M.D.
   
4. Bipolar Disorder in the Older Patient Brent P. Forester, M.D.
   
5. Recognizing Bipolar Disorder in African Americans William B. Lawson, M.D.
   

IS6. Verging on Reality: Emergent Therapeutic Approaches for Schizophrenia Supported by Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc.

1. Functional Genomics and the Therapeutic Effects of Antipsychotics Anil K. Malhotra, M.D.
   
2. Insights From Neuroimaging to Guide Drug Choice and Development Carol A. Tamminga, M.D.
   
3. The Science of Subjective Tolerability: "Wellness" as a Treament Outcome Meera Narasimhan, M.D.
   
4. Recovery and Remission: Definitions, Dilemmas, and the Emergent Role of Peer Support Peter F. Buckley, M.D.
   

IS7. Bipolar Disorder: Creating a Consensus From Science to Public Policy Supported by Solvay Wyeth Pharmaceuticals

1. Treatment Considerations for Mania in Young Children Barbara Geller, M.D.
   
2. Treatment of Bipolar Disorder in U.S. Jails and Prisons Joseph R. Calabrese, M.D.
   
3. The Impact of Psychosocial Treatment on the Course and Prognosis of Bipolar Disorder Ellen Frank, Ph.D.
   
4. A Rational Approach for the Longitudinal Pharmacologic Management of Patients With Bipolar Disorder: An Argument for Changing Public Policy Mark H. Rapaport, M.D.
   
5. Alternative Pharmacologic Approaches to the Care of Bipolar Patients Alexander H. Fan, M.D.
   

IS8. Treatment-Resistant Depression: New Data, New Approaches Supported by Cyberonics, Inc.

1. Definitions and Clinical Characteristics of Treatment-Resistant Depression David L. Dunner, M.D.
   
2. Treatment Resistance and Genes: The Biology Versus Pharmacology Enigma Francisco A. Moreno, M.D.
   
3. PET of Chronic Vagal Nerve Stimulation in Severe, Treatment-Resistant Depression Jose V. Pardo, M.D.
   
4. Augmentation Strategies for Patients With Difficult-to-Treat MDD Alicia R. Ruelaz, M.D.
   
5. Brain Stimulation Therapies for Treatment-Resistant Depression Linda L. Carpenter, M.D.
   

Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles via Google Scholar Search for Related Content

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us